Common Names: Carphedon, Fonturacetam, Phenotropil
Scientific Names: (R,S)-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide
Phenylpiracetam, also known as Phenotropil, is a racetam drug derived from Piracetam, with the sole modification being the addition of a phenyl group to its structure. This alteration allows for similar cognitive benefits at much lower doses and introduces psychostimulatory effects. As a nootropic of the racetam family, Phenylpiracetam is recognized for its reported neuroprotective properties compared to Piracetam, along with psychostimulation and enhanced physical performance. Research suggests effectiveness in attenuating cognitive decline symptoms over an extended period, particularly in cases of dementia and stroke. Animal studies indicate potential anti-amnesic, antidepressant, anticonvulsant, anxiolytic, and memory enhancement effects. Small clinical trials link Phenylpiracetam to improvements in encephalopathic conditions, including cerebral blood pathway lesions, traumatic brain injury, and certain gliomas.
It is essential to note that while Phenylpiracetam has been the subject of research exploring its potential cognitive and neurological effects, any consideration of supplementation should be approached with caution. The information provided here is based on available studies, but individual responses to such substances can vary, and the long-term safety and efficacy of Phenylpiracetam in humans remain subjects of ongoing research. It is strongly advised to consult with a qualified healthcare professional before considering any form of supplementation, as they can provide personalized guidance based on individual health conditions, medications, and potential interactions. Additionally, the availability and legal status of Phenylpiracetam may vary by country, and it is crucial to adhere to local regulations and medical advice when considering its use.